Please ensure Javascript is enabled for purposes of website accessibility

AptarGroup Dispenses a Nearly Flawless Quarter

By Steve Symington - Feb 13, 2018 at 8:46PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The dispensing systems specialist ended 2017 on a high note and expects more strength ahead.

AptarGroup Inc. (ATR -0.29%) released another better-than-expected quarter on Monday after the market closed. The dispensing-systems leader highlighted healthy core sales growth in each of its business segments and geographies, punctuated by improvements at the Beauty+Home segment and strong growth in the pharma space.

With shares up nearly 9% on Tuesday, let's take a deeper look at how AptarGroup ended the year, as well as what investors can expect from the company in the coming quarters.

Aptar pharmaceutical bottles


AptarGroup results: The raw numbers


Q4 2017

Q4 2016

Year-Over-Year Growth


$625.9 million

$538.9 million


Net income

$49.5 million

$49.6 million


Earnings per diluted share





What happened with AptarGroup this quarter?

  • On a non-GAAP basis -- which adjusts for a $0.12-per-share negative impact from recent tax legislation and $0.03 per share in restructuring charges, as well as an $0.11-per-share gain on insurance recovery -- Aptar's earnings were $0.81 per share.
  • By comparison, AptarGroup's latest guidance called for lower per-share earnings of $0.68 to $0.73.
  • Excluding a positive 6% impact from foreign currency exchange, core sales grew 10%.
  • By segment:
    • Beauty+Home sales grew 16%, including 10% core sales growth and a 6% contribution from foreign currency exchange.
    • Pharma sales increased 18%, including 11% core sales growth and a 7% contribution from currencies.
    • Food+Beverage sales grew 14%, including 11% core sales growth and a 3% increase from currencies.
  • Adjusted EBITDA grew 9% to $118 million.

What management had to say

AptarGroup CEO Stephen Tanda elaborated:

This was a strong quarter with robust and wide-spread demand for our innovative dispensing and drug delivery systems. Core sales grew across each business segment, and in each end market and geographic region. Our Beauty + Home segment built on the momentum experienced in the third quarter, particularly the recovery in demand from the beauty market. Our Pharma segment experienced strong growth in the prescription drug and consumer healthcare markets as demand rose for allergy and asthma related devices, as well as for decongestant nasal sprays and saline systems. Our Food + Beverage segment grew sales in each market and continued to penetrate the vast beverage market with our value-adding dispensing closures. With the sales growth and our continued drive to capture value and contain costs, each segment reported adjusted EBITDA growth over the prior year. 

Looking forward

AptarGroup expects this positive momentum to carry through to the first quarter of 2018, with continued top-line growth from each segment on a year over-year basis.

Tanda also cautioned, however, that despite high expectations for tax-rate reductions from recent U.S. tax reform, Aptar anticipates it will see "little benefit" to its overall effective tax rates in the near term -- primarily a consequence of the new legislation's tax effects on its international business.

Still, AptarGroup expects first-quarter adjusted earnings per share in the range of $0.90 to $0.95 -- comfortably ahead of investors' expectations for Q1 earnings of $0.89 per share.

In the end, there was little not to like about AptarGroup's latest performance, and the company offered plenty of reason to be optimistic for the future even despite dashing hopes for a tax-centric windfall. As such, it should be no surprise to see AptarGroup stock touching a fresh all-time high today.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

AptarGroup, Inc. Stock Quote
AptarGroup, Inc.
$103.09 (-0.29%) $0.30

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.